中晚期原发性肺癌BAI后影响近期疗效的因素分析  

Analysis of Factors Influencing Later Curative Effect in Mid-advanced Stage Primary Pulmonary Carcinoma after BAI.

作　　者：黄子诚[1] 陈胜利[1] 

机构地区：[1]广州市第一人民医院介入放射科,510180

出　　处：《医学研究杂志》2009年第3期28-30,共3页Journal of Medical Research

摘　　要：目的研究BAI后影响近期疗效的单因素。方法对82例原发性肺癌的病例进行支气管动脉/相关体动脉造影与灌注化疗(BAI)。对肿瘤病理类型、肿瘤血供多少、临床TNM分期、灌注化疗用药方案、供血血管支数、有效动脉灌注治疗次数等7个方面与BAI后近期疗效的关系进行统计学分析;采用SPSS 13.0 for Windows统计软件包,计数资料采用列联表卡方检验,计量资料采用T检验、GLM分析等,以P<0.05为有显著性意义,P<0.01为有非常显著性意义。结果除肿瘤血供多少与有效BAI次数影响近期疗效外,其他几项因素对近期疗效的影响都无统计学意义。结论肺癌血供状态分型、有效BAI治疗次数,是影响近期疗期的因素。Objective To study later curative effects after BAI with single factor analysis. Methods Bronchus artery and relational body arteries opacification and BAI had been introduced in 82 primary pulmonary carcinoma cases. In the statistic analysis, SPSS 13.0 had been used. Results The tumour blood supply types and the times of effective BAI treatment were the factors influencing the later treatment period. Tumour pathologic types, the branches of tumour blood supply, tumour clinic cTNM stages, chems project influenced faintly later curative effect. Conclusion The blood supply types of primary pulmonary carcinoma and the times of effective BAI treatment are the factors influencing the later treatment period.

关 键 词：原发性肺癌 灌注化疗 支气管动脉 近期疗效 影响因素 

分 类 号：R273.42[医药卫生—中西医结合] R734.2[医药卫生—中医肿瘤科]